CI & Patents News (Pharma): 14/02/2011


1) Brazil to produce generic AIDS and hepatitis drugs (thepharmaletter); Brazil’s health authority, ANVISA, has licensed the generic version of tenofovir to the official laboratory Fundacao Ezequiel Dias (Funed – run by the government of the state of Minas Gerais). This has been made possible by a public-private partnership, facilitated by the Department of Science, Technology and Strategic Inputs (SCTIE) at the Ministry of Health.

2) Sandoz has 10 biosimilars in pipeline (Biospace)

3) Sun Pharma Freezes Generic Eloxatin Sales (law360)

4) AstraZeneca Targets Korean Co. Over Nexium Patents (law360); View on RFCexpress

5) Novartis Sues Mylan for Generic Fluvastatin ANDA (Philip Brooks’ Patent Infringement Updates); Novartis filed complaint on two district courts (Delaware) (West Virginia Northern District Court)

6) Pharma patents in Mexico: an assessment of the current position (IP Tango)

7) EPOorg: Beta version of new EPO website now available (EPO)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news. Bookmark the permalink.

3 Responses to CI & Patents News (Pharma): 14/02/2011

  1. Pingback: CI & Patents News (Pharma): 14/02/2011 « PATENT DAILY

  2. Pingback: CI & Patents News (Pharma): 14/02/2011 « PATENT DAILY | Fantastic Legal Information

  3. Pharmg474 says:

    Hello! cdkfeed interesting cdkfeed site!

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s